Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic

Abu Montakim Tareq; Talha Bin Emran; Kuldeep Dhama; Manish Dhawan; Trina Ekawati Tallei

doi:10.1080/21645515.2021.1963601

Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic

Hum Vaccin Immunother. 2021 Nov 2;17(11):4126-4127. doi: 10.1080/21645515.2021.1963601. Epub 2021 Sep 2.

Authors

Abu Montakim Tareq¹, Talha Bin Emran², Kuldeep Dhama³, Manish Dhawan^{4

5}, Trina Ekawati Tallei^{6

7}

Affiliations

¹ Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
² Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh.
³ Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
⁴ Department of Microbiology, Punjab Agricultural University, Ludhiana, India.
⁵ The Trafford Group of Colleges, Manchester, UK.
⁶ Department of Biology, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado, Indonesia.
⁷ The University Centre of Excellence for Biotechnology and Conservation of Wallacea, Institute for Research and Community Services, Sam Ratulangi University, Manado, Indonesia.

No abstract available

Keywords: COVID-19; SARS-CoV-2; delta variant (B.1.617.2); second wave; vaccines.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Humans
Pandemics / prevention & control
SARS-CoV-2
Vaccines*

Substances

Vaccines

Supplementary concepts

SARS-CoV-2 variants

Grants and funding

The authors would like to thank the Ministry of Education and Culture, Research and Technology, Republic of Indonesia, for funding the publication of this letter, through the Basic Research scheme for the Fiscal Year 2021 (Contract number: 1997/UN12.13/LT/2021).